Praxis Biotech Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Praxis Biotech General Information


Developer of drugs designed to develop small molecules to be used as drugs in human diseases. The company's drugs are made from synthetic molecules for pharmaceutical use in fighting human diseases, enabling doctors to help patients in treatment of Parkinson's and Alzheimer's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 1700 Owens Street
  • Suite 515
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

Praxis Biotech Timeline

Date FoundedFinancing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Praxis Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-May-2019 Completed Startup
1. Equity Crowdfunding 22-Apr-2019 00000 Completed Startup
To view Praxis Biotech’s complete valuation and funding history, request access »

Praxis Biotech Executive Team (8)

Name Title Board Seat Contact Info
Sebastian Bernales Ph.D Co-Founder & Chief Executive Officer
Agustin Huneeus Co-Founder
Eduardo Ergas Co-Founder
Marc Shuman MD Co-Founder
Pablo Valenzuela Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

Praxis Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fen Ventures Venture Capital Minority 000 0000 000000 0
To view Praxis Biotech’s complete investors history, request access »